| Entry |
|
|---|
| Name |
Nimustine (INN) |
|---|
| Formula |
C9H13ClN6O2
|
|---|
| Exact mass |
272.0789
|
|---|
| Mol weight |
272.69
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
| Product (DG00679): | D01059<JP> |
|
|---|
| Efficacy |
Antineoplastic, Alkylating agent |
|---|
| Comment |
Nitrosourea
|
|---|
| Target |
DNA |
|---|
| Interaction |
|
|---|
| Structure map |
| map07040 | Antineoplastics - alkylating agents |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AD Nitrosoureas
L01AD06 Nimustine
D08276 Nimustine (INN)
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG01724 Nitrosourea
DG00679 Nimustine
D08276 Nimustine
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG01724 Nitrosourea
DG00679 Nimustine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 18
1 C8y C 19.3200 -19.3200
2 N5x N 19.3200 -17.9200
3 C8y C 20.5800 -17.2200
4 C8y C 21.7700 -17.9200
5 C8x C 21.7700 -19.3200
6 N5x N 20.5800 -20.0200
7 C1a C 18.0600 -20.0200
8 N1a N 20.5800 -15.8200
9 C1b C 23.0300 -17.2200
10 N1b N 24.2200 -17.9200
11 C5a C 25.4100 -17.2200
12 O5a O 25.4100 -15.8200
13 N1c N 26.6700 -17.9200
14 C1b C 27.8600 -17.2200
15 C1b C 29.0500 -17.9200
16 X Cl 30.2400 -17.2900
17 N2b N 26.6700 -19.3200
18 O3a O 25.4100 -20.0200
BOND 18
1 2 3 1
2 9 10 1
3 3 4 2
4 10 11 1
5 4 5 1
6 11 12 2
7 5 6 2
8 11 13 1
9 6 1 1
10 13 14 1
11 14 15 1
12 1 7 1
13 15 16 1
14 13 17 1
15 3 8 1
16 1 2 2
17 4 9 1
18 17 18 2
|
|---|
